Hsinchu County, Taiwan

Ching-Yuan Lee


Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Bao-shan Xiang, Hsinchu County, TW (2016)
  • Hsinchu County, TW (2017)
  • Bao-shan Xiang, TW (2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Ching-Yuan Lee

Introduction

Ching-Yuan Lee is a notable inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of thrombocytopenia. With a total of 3 patents to his name, his work has the potential to impact the lives of many patients suffering from related conditions.

Latest Patents

One of his latest patents focuses on the treatment of thrombocytopenia using orally administered interferon. This innovative interferon composition is designed to enhance platelet count, reduce the recurrence rate of hepatitis, and improve the social function of hepatitis patients. The method involves administering a low dose of interferon (about 5 IU to about 2500 IU of IFN-alpha) to patients in need. In this patent, the interferon can be either alpha IFN or beta IFN, with a specific emphasis on human alpha IFN as the biologically active component.

Career Highlights

Ching-Yuan Lee is currently associated with Amarillo Biosciences, Inc., where he continues to develop and refine his innovative treatments. His work is characterized by a commitment to improving patient outcomes through scientific advancements.

Collaborations

He has collaborated with notable colleagues, including Martin Joseph Cummins and Chau-Ting Yeh, who contribute to the research and development efforts at Amarillo Biosciences, Inc.

Conclusion

Ching-Yuan Lee's contributions to the field of medicine through his patents and collaborations highlight his dedication to innovation and improving healthcare solutions. His work in treating thrombocytopenia showcases the potential of scientific advancements in enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…